Avalyn Pharma (AVLN) AI Analysis
AVLN$30.28-0.31 -1.01%
Market cap$1.35BEnterprise value$907.35MRevenue (TTM)$0Market position—
Score
71
Bullish
Value
64
Quality
50
Growth
100
Avalyn Pharma Inc. Common Stock is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 71/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~98% upside.